Search Results for "Sng001"
17:34 EDT 25th May 2013 | BioPortfolio
Matching Channels
None
Matching News
Synairgen in drug partnership talks after study results
Synairgen Plc is in talks with potential partners following the results of a study of an experimental medicine targeting infections that trigger asthma attacks, Chief Executive Officer Richard Marsd...
Synairgen raises £2.5 million to advance respiratory drug
Synairgen (LON:SNG) has raised £2.5 million through a placing to advance the progress of its asthma drug, it was revealed. It comes after the firm announced in April positive data from its Phas...
Matching PubMed Articles
None
Search Whole site using Google
Loading
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
